Clinical Trial Update: The Prospective Study on the Effect of Ilaprazole in Non-erosive Reflux Disease Patients; Focused on Histologic Findings and Inflammatory Biomarker [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating the effect of ilaprazole in non-erosive reflux disease, focusing on histologic findings and inflammatory biomarkers; the study is com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Subepithelial Tumors

Drugs mentioned

• Ilaprazole (ilaprazole)

Snippet

Sponsor: Yonsei University | Conditions: Gastrointestinal Subepithelial Tumors | Phase 4 | Status: COMPLETED